Cancer

The latest cancer news from UNC Health Care and the UNC School of Medicine.

Improved ultrasound imaging provides alternate way to visualize tumors

Improved ultrasound imaging provides alternate way to visualize tumors

The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.

Improved ultrasound imaging provides alternate way to visualize tumors - Read More…

Early tumor response from stereotactic radiosurgery predicts outcome

Early tumor response from stereotactic radiosurgery predicts outcome

This research could reduce the need to continually monitor patients who respond well to stereotactic radiosurgery.

Early tumor response from stereotactic radiosurgery predicts outcome - Read More…

A powerful technique to further understanding of RNA

A powerful technique to further understanding of RNA

Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.

A powerful technique to further understanding of RNA - Read More…

Top of the Line

Top of the Line

The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.

Top of the Line - Read More…

Out-of-pocket costs play major role in treatment adherence for cancer patients

Out-of-pocket costs play major role in treatment adherence for cancer patients

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.

Out-of-pocket costs play major role in treatment adherence for cancer patients - Read More…

Muss honored with ACTO Richard L. Schilsky Award

Muss honored with ACTO Richard L. Schilsky Award

The award, which includes $5,000 in direct research support, recognizes years of service to the CALGB cooperative group by Dr. Muss, who has been a member for more than 30 years.

Muss honored with ACTO Richard L. Schilsky Award - Read More…

Screening decisions must balance potential benefits with potential patient harms

Screening decisions must balance potential benefits with potential patient harms

Screening to detect medical conditions has become standard practice for many diseases, but insufficient attention has been paid to the potential for harm, according to research by a team led by Russell Harris, MD, MPH, of the UNC School of Medicine, UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center.

Screening decisions must balance potential benefits with potential patient harms - Read More…

UNC scientists find potential cause for deadly breast cancer relapse

UNC scientists find potential cause for deadly breast cancer relapse

Adriana S. Beltran, PhD, a research assistant professor in the UNC School of Medicine, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas, and she designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.

UNC scientists find potential cause for deadly breast cancer relapse - Read More…

Salie Babilonia:  How “The Look” Speaks Volumes

Salie Babilonia: How “The Look” Speaks Volumes

A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.

Salie Babilonia: How “The Look” Speaks Volumes - Read More…

Carolina Breast Cancer Study enrolls record 3,000 participants

This milestone makes the Carolina Breast Cancer Study the largest-ever population-based study of breast cancer in North Carolina and one of the largest in the world.

Carolina Breast Cancer Study enrolls record 3,000 participants - Read More…

UNC researchers win drug-discovery awards from pharmaceutical giant GSK

GlaxoSmithKline drug-discovery competition winners aim to find a new cancer therapy and a novel way to regulate male fertility, projects spearheaded by scientists at the UNC School of Medicine.

UNC researchers win drug-discovery awards from pharmaceutical giant GSK - Read More…

Understanding Our Immunity

Understanding Our Immunity

Five questions for Yisong Wan, a new Jefferson-Pilot fellow who is uncovering the roles of T cells in disease cures and causes.

Understanding Our Immunity - Read More…

Promising new therapy in a smaller package

Promising new therapy in a smaller package

A new microbeam emitter developed at the University of North Carolina at Chapel Hill by a team led by UNC Lineberger member Otto Zhou has the potential to bring a promising new form of radiation therapy into clinical use.

Promising new therapy in a smaller package - Read More…

Single Fathers Due to Cancer Google+ hangout set for Nov. 1

Single Fathers Due to Cancer Google+ hangout set for Nov. 1

Join us at 11 a.m. Eastern time on Friday, Nov. 1, for a discussion of how fathers cope with the loss of their wife or partner, meet the demands of sole parenthood, and manage their children's grief.

Single Fathers Due to Cancer Google+ hangout set for Nov. 1 - Read More…

From hospice volunteer to cancer doctor

From hospice volunteer to cancer doctor

Five questions for Ronald Chen, a James Woods Young Faculty Award recipient dedicated to bettering treatment for cancer patients.

From hospice volunteer to cancer doctor - Read More…

Walking program reduces joint stiffness in older breast cancer survivors on aromatase inhibitor therapy

Walking program reduces joint stiffness in older breast cancer survivors on aromatase inhibitor therapy

After six weeks of walking, the mean joint pain scores among the participants decreased by 10 percent, fatigue decreased by 19 percent, and joint stiffness decreased by 32 percent.

Walking program reduces joint stiffness in older breast cancer survivors on aromatase inhibitor therapy - Read More…

Physicians experience increased effort, uncertainty in cross-coverage of radiation oncology patients

Radiation oncology physicians who encounter an unfamiliar case when cross-covering for another physician experience higher levels of perceived workload and may also affect performance, according to research conducted at the University of North Carolina.

Physicians experience increased effort, uncertainty in cross-coverage of radiation oncology patients - Read More…

Share This: